ArticleBMC cancer2025
BMI and PNI as predictors of treatment completion and survival in locally advanced HNSCC receiving sequential chemoradiotherapy.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the clinical and laboratory factors affecting treatment response and treatment tolerance in patients diagnosed with head and neck squamous cell carcinoma (HNSCC) and treated with chemoradiotherapy (CRT) after three cycles of induction chemotherapy.
methodPatients who were followed up in the oncology clinic between January 2014 and December 2024 and who could not undergo an organ-sparing approach or surgery were analyzed retrospectively. Demographic, clinical, biochemical and inflammatory parameters of the patients were examined. Binary-logistic regression analysis was used for patients who could not complete the treatment due to toxicity, Cox-regression analysis was used to investigate the factors affecting overall survival (OS), and Roc-curve analysis was used to determine the ideal-cut-off values for blood markers.
resultsA total of 92 patients with HNSCC were included in the study. In univariate logistic regression analysis, age ≥ 60 (p = 0.006), presence of comorbidity (p = 0.029), body mass index (BMI) < 23.25 (p = 0.005), poor ECOG performance score (2-3) (p < 0.001) and low prognostic nutritional index (PNI) (p = 0.011) were found to be significant risk factors for not completing treatment. Multivariate logistic regression of age, BMI, ECOG, and PNI together formed a predictive model for treatment incompletion. In Cox regression analysis, BMI <23.25 (p=0.016), poor ECOG performance score (2-3) (p=0.002), advanced disease stage (p=0.002), and low PNI (<51.1) (p=0.006) were the main risk factors for unfavorable overall survival. Gender, smoking, tumor location, treatment regimen, and hematological parameters had no significant effect on survival and treatment completion.
conclusionIn HNSCC patients who underwent post-induction CRT, nutritional parameters such as BMI and PNI and performance status play a determining role on treatment tolerance and survival. Detailed assessment of nutritional status before treatment may have an impact on treatment success and survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.